Literature DB >> 3432104

Heparinization during percutaneous cardiac catheterization in children.

H Netz1, B Madu, G Röhner.   

Abstract

The effect of heparin on blood clotting was studied by measuring the activated clotting time (ACT) in 120 infants and children with congenital heart disease after a single intravenous bolus of 100 IU heparin/kg body weight. Before heparinization, infants and children with cyanotic heart disease showed signs of hypocoagulation. Heparin bolus led to a threefold increase of ACT after 15 min. After 1 h, the ACT was still two times the normal value. Any further administration of heparin may be based on ACT monitoring.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3432104     DOI: 10.1007/BF02263447

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  3 in total

1.  Statistical correlation and heparin sensitivity of activated partial thromboplastin time, whole blood coagulation time, and an automated coagulation time.

Authors:  H G Schriever; S E Epstein; M D Mintz
Journal:  Am J Clin Pathol       Date:  1973-09       Impact factor: 2.493

2.  A simple method of heparin management during prolonged extracorporeal circulation.

Authors:  J D Hill; L Dontigny; M De Leval; C H Mielke
Journal:  Ann Thorac Surg       Date:  1974-02       Impact factor: 4.330

3.  Heparinization for prevention of thrombosis following pediatric percutaneous arterial catheterization.

Authors:  D A Girod; R A Hurwitz; R L Caldwell
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

  3 in total
  1 in total

1.  Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization.

Authors:  Maria L Avila; Prakeshkumar S Shah; Leonardo R Brandão
Journal:  Cochrane Database Syst Rev       Date:  2020-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.